Obesity or overweight with diabetes
Cch x tr khi qun liu, qu liu Qun liu: Dng liu thay th ngay khi nh ra
M.DiakogiannakiE.et al (2012)
Despite how common GLP-1 use has become, there has been relatively little dermatology-focused research on their cutaneous side effects, with most of the existing literature limited to individual case reports. For the cross-sectional analysis, researchers compared cutaneous adverse events reported in the FDA Adverse Event Reporting System (FAERS) for the GLP-1 receptor agonists semaglutide (Ozempic/ Wegovy, Novo Nordisk), liraglutide, exenatide and dulaglutide (Trulicity, Eli Lilly) with cutaneous adverse event reports for the dipeptidyl peptidase-4 (DPP-IV) inhibitors sitagliptin, saxagliptin, linagliptin and alogliptin
Skin Concerns - Our Naturopaths work with many common skin issues at our Edmonton clinic with Acne, Eczema and Psoriasis being the most commonly seen
Its not a direct effect of the medication, but losing weight quickly without enough protein or physical activity can lead to muscle loss